FPHAX Holdings Information

FPHAX is a mutual fund with a total of 65 individual holdings. The top holdings are Eli Lilly and Company stock at 25.89%, GSK plc at 8.19%, Merck & Co. at 5.83%, Viatris at 4.99%, and UCB SA at 4.86%.

Total Holdings

Top 10 Percentage

71.16%

Asset Class

Equity

Fund Category

Health

Assets

1.57B

Forward PE Ratio

16.55

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	25.89%	345,601
2	GSK	GSK plc	8.19%	2,500,060
3	MRK	Merck & Co., Inc.	5.83%	726,036
4	VTRS	Viatris Inc.	4.99%	5,032,300
5	EBR: UCB	UCB SA	4.86%	260,100
6	LON: AZN	AstraZeneca PLC	4.53%	382,350
7	LEGN	Legend Biotech Corporation	4.52%	2,508,300
8	SWX: ROP	Roche Holding AG	4.40%	170,940
9	ELAN	Elanco Animal Health Incorporated	4.01%	2,611,000
10	GILD	Gilead Sciences, Inc.	3.94%	499,200
11	JAZZ	Jazz Pharmaceuticals plc	3.91%	259,600
12	JNJ	Johnson & Johnson	2.80%	176,400
13	RPRX	Royalty Pharma plc	2.42%	692,000
14	MRNA	Moderna, Inc.	2.06%	470,100
15	BNTX	BioNTech SE	1.54%	265,453
16	BMY	Bristol-Myers Squibb Company	1.48%	410,300
17	NTLA	Intellia Therapeutics, Inc.	1.23%	1,165,300
18	BEAM	Beam Therapeutics Inc.	1.07%	500,600
19	AXSM	Axsome Therapeutics, Inc.	0.96%	62,700
20	PFE	Pfizer Inc.	0.95%	634,700
21	XENE	Xenon Pharmaceuticals Inc.	0.85%	226,000
22	OCUL	Ocular Therapeutix, Inc.	0.82%	1,331,717
23	KYMR	Kymera Therapeutics, Inc.	0.61%	84,500
24	PTCT	PTC Therapeutics, Inc.	0.56%	110,000
25	DFTX	Definium Therapeutics, Inc.	0.55%	188,000

Showing 25 of 65 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026